Mewburn Ellis LLP

Partner, Solicitor, Patent Litigator

Amy is a highly accomplished patent litigator with a wealth of experience in the pharmaceutical and biotech industries. Amy has played a pivotal role in numerous high-profile cases concerning some of the highest revenue drugs on the market.  Her experience spans the full spectrum of life sciences patent disputes before the UK courts, ranging from small molecule and biologic disputes to the UK’s first gene therapy patent case to go to trial.

She also has extensive experience of coordinating multi-jurisdictional litigation across Europe and with the US, as well as aligning litigation strategy with opposition proceedings before the EPO.

Amy also has experience of acting for clients on UPC litigation and of advising clients on the ever-increasing importance of UPC litigation strategy and its integration with UK and European national litigation strategy.

AIPPI
ChIPs

Amy has an MSci in Biochemistry (First Class Honours) from Imperial College London. She went on to study law, qualified as a solicitor in 2011 and obtained the Postgraduate Diploma in IP Law and Practice from the University of Oxford. 

Amy is passionate about diversity and inclusion and is the co-chair of the London chapter of ChIPs, a prominent organisation that promotes women in tech, law and policy. She is also on the organising committee for the annual ChIPs European Summit.

She is a lecturer on patent validity at the IP Law Summer School at the University of Cambridge and was previously an organiser of the IP module of the University of Cambridge’s MPhil in Bioscience Enterprise.